Healthy volunteers needed to test two versions of heart drug

NCT ID NCT07422285

Recruiting now Knowledge-focused Sponsor: Amgen Source: ClinicalTrials.gov ↗

First seen Feb 23, 2026 · Last updated May 15, 2026 · Updated 8 times

Summary

This study tests how the body handles two different forms of evolocumab, a drug used to lower cholesterol. About 400 healthy adults aged 18 to 60 will receive a single dose and be monitored for drug levels and side effects. The goal is to compare the two versions, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fortrea Clinical Research Unit - Dallas

    RECRUITING

    Dallas, Texas, 75247, United States

  • Fortrea Clinical Research Unit - Daytona Beach

    RECRUITING

    Daytona Beach, Florida, 32117-5116, United States

  • Fortrea Clinical Research Unit Inc. - Madison

    RECRUITING

    Madison, Wisconsin, 53704-2526, United States

  • Ohio Clinical Trials, Inc.

    RECRUITING

    Columbus, Ohio, 43212, United States

  • QPS Bio-Kinetic

    RECRUITING

    Springfield, Missouri, 65802-4842, United States

Conditions

Explore the condition pages connected to this study.